Objectives	To be able to perform specialist assessment, treatment and counselling of patients with cancer and comorbidities
Awareness	Recognition of the importance of interdisciplinary management of patients with cancer with comorbidities Appreciation of the principles of integrating comorbidities into diagnostic and treatment decisions for patients with cancer Awareness of the importance of comorbidity assessment in determining clinical trial eligibility Awareness of the existence of prognostic comorbidity indices Recognition of the psychosocial impact of cancer treatment in patients with comorbidities
Knowledge	Understanding of how comorbid medical conditions can affect the efficacy and toxicity of cancer treatment Understanding that comorbidities may influence but are not equivalent to functional status Understanding of how to individualise the management of different cancers in patients with comorbidities Understanding of how cancer-directed treatment can lead to the exacerbation of comorbidities during or after the completion of therapy Understanding of the distinction between disease progression, treatment-related toxicities and complications related to comorbidities Familiarity with specific comorbidities which may be contraindications to surgery, radiation therapy, chemotherapeutics, immunotherapy or targeted therapy in different cancers Familiarity with the utility and limitations of tools such as the Charlson Index in assessing the impact of comorbid medical conditions on outcomes in patients with cancer
Skills	Ability to perform a through and accurate assessment of a cancer patient's comorbid medical conditions Ability to consider how cardiovascular, pulmonary, haematological, gastrointestinal, autoimmune, rheumatological, neurological, infectious, endocrine, dermatological and psychiatric comorbid conditions and their treatment affect a patient's ability to receive a particular cancer-directed therapy Ability to discuss critically and coordinate the management of comorbidities of patients with cancer with other specialists Ability to include understanding of comorbidities in referrals for radiological and interventional diagnostic and therapeutic procedures in patients with cancer Ability to apply understanding of drug pharmacology to adapt and modify therapeutic plans in patients with cancer with comorbidities, including varying degrees of hepatic and renal dysfunction Ability to consider comorbidities to identify frail/unfit patients with cancer and to determine clinical trial eligibility Ability to incorporate comorbidities in determining the risk/benefit ratio for pursuing cancer-directed therapy and for specific anticancer agents Ability to anticipate potential acute and chronic treatment-related complications (eg, neuropathy) in patients with cancer with comorbidities Ability to contribute actively in the management of patients with cancer with comorbidities at the time of diagnosis, and during the initiation, transition and cessation of treatment Ability to integrate the presence of comorbidities, along with age, cognitive and performance status into developing multidisciplinary treatment plans for patients with cancer Ability to manage toxicities of chemotherapeutic, targeted and immunotherapeutic agents in the setting of comorbidities, including drug-dosing adjustments and administering supportive measures Ability to consider drug–drug interactions when prescribing different therapeutic agents in patients with cancer with comorbidities Ability to determine alternate drug regimens and schedules for patients with cancer with different comorbidities Ability to discuss the role of comorbidities in treatment decision-making with patients with cancer